Risk of squamous cell carcinoma in patients with hidradenitis suppurativa treated with anti‐TNF‐alpha—Results from a 12‐year multicentric observational prospective study-Reference-Cited by-同舟云学术

Risk of squamous cell carcinoma in patients with hidradenitis suppurativa treated with anti‐TNF‐alpha—Results from a 12‐year multicentric observational prospective study

Published:2024-02-26 Issue:9 Volume:38 Page:
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Smetanová Alžběta¹^ORCID,Pásek Marek¹^ORCID,Marques Emanuel¹²^ORCID,Vránová Jana³,Arenberger Petr¹^ORCID,Machovcová Alena⁴,Horáčková Zuzana⁴,Arenbergerová Monika¹^ORCID,

Affiliation:

1. Department of Dermatology and Venereology, Third Faculty of Medicine Charles University and Královské Vinohrady University Hospital Prague Czech Republic

2. Department of Pharmacology, Second Faculty of Medicine Charles University Prague Czech Republic

3. Department of Medical Biophysics and Medical Informatics, 3rd Faculty of Medicine Charles University Prague Czech Republic

4. Department of Dermatology and Venerology University Hospital Motol Prague Czech Republic

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.19916

Reference7 articles.

1. Squamous cell carcinoma complicating a chronic lesion of hidradenitis suppurativa: a case report and review of the literature

2. Clinicopathological Study of 13 Cases of Squamous Cell Carcinoma Complicating Hidradenitis Suppurativa

3. Squamous cell carcinoma in hidradenitis suppurativa lesions following tumor necrosis factor α inhibitors;Cooper SD;Cutis,2021

4. Risk of melanoma and nonmelanoma skin cancer with immunosuppressants, part II: Methotrexate, alkylating agents, biologics, and small molecule inhibitors

5. Neoplastic implications in patients suffering from hidradenitis suppurativa under systemic treatments;Li Pomi F;Biomedicine,2021